

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 7.24007743 |
| 2 | cardiac myofibril assembly (GO:0055003) | 7.16607793 |
| 3 | * tricarboxylic acid cycle (GO:0006099) | 6.80846579 |
| 4 | skeletal muscle contraction (GO:0003009) | 6.60822177 |
| 5 | myofibril assembly (GO:0030239) | 6.05133830 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.86163468 |
| 7 | muscle filament sliding (GO:0030049) | 5.69383753 |
| 8 | actin-myosin filament sliding (GO:0033275) | 5.69383753 |
| 9 | cardiac muscle cell development (GO:0055013) | 5.51532454 |
| 10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.45407956 |
| 11 | cardiac muscle contraction (GO:0060048) | 5.35820159 |
| 12 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.18129032 |
| 13 | cardiac cell development (GO:0055006) | 5.17453040 |
| 14 | oxidative phosphorylation (GO:0006119) | 5.16899925 |
| 15 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.16896867 |
| 16 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.04254076 |
| 17 | carnitine shuttle (GO:0006853) | 4.88852707 |
| 18 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.85508616 |
| 19 | heart contraction (GO:0060047) | 4.75503284 |
| 20 | heart process (GO:0003015) | 4.75503284 |
| 21 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.66765899 |
| 22 | lysine metabolic process (GO:0006553) | 4.65046472 |
| 23 | lysine catabolic process (GO:0006554) | 4.65046472 |
| 24 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.60207606 |
| 25 | actin-mediated cell contraction (GO:0070252) | 4.59716707 |
| 26 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.59116648 |
| 27 | regulation of sarcomere organization (GO:0060297) | 4.58365851 |
| 28 | heart trabecula formation (GO:0060347) | 4.54691359 |
| 29 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.51652893 |
| 30 | actomyosin structure organization (GO:0031032) | 4.50450540 |
| 31 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.50256848 |
| 32 | NADH metabolic process (GO:0006734) | 4.49482333 |
| 33 | cardiac muscle hypertrophy (GO:0003300) | 4.49050242 |
| 34 | regulation of actin filament-based movement (GO:1903115) | 4.47741476 |
| 35 | adult heart development (GO:0007512) | 4.42866805 |
| 36 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.42839918 |
| 37 | ATP synthesis coupled proton transport (GO:0015986) | 4.42839918 |
| 38 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.39717495 |
| 39 | fatty acid transmembrane transport (GO:1902001) | 4.33737125 |
| 40 | regulation of coenzyme metabolic process (GO:0051196) | 4.32888365 |
| 41 | regulation of cofactor metabolic process (GO:0051193) | 4.32888365 |
| 42 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.32049606 |
| 43 | regulation of relaxation of muscle (GO:1901077) | 4.29474258 |
| 44 | fatty acid beta-oxidation (GO:0006635) | 4.28685293 |
| 45 | striated muscle hypertrophy (GO:0014897) | 4.22609503 |
| 46 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.19525417 |
| 47 | muscle tissue morphogenesis (GO:0060415) | 4.15140566 |
| 48 | negative regulation of cell size (GO:0045792) | 4.12865019 |
| 49 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.12599248 |
| 50 | regulation of skeletal muscle contraction (GO:0014819) | 4.10483207 |
| 51 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.98939690 |
| 52 | aspartate family amino acid catabolic process (GO:0009068) | 3.97983870 |
| 53 | response to inactivity (GO:0014854) | 3.96000676 |
| 54 | striated muscle contraction (GO:0006941) | 3.92399485 |
| 55 | plasma membrane repair (GO:0001778) | 3.90846160 |
| 56 | * 2-oxoglutarate metabolic process (GO:0006103) | 3.89679201 |
| 57 | branched-chain amino acid catabolic process (GO:0009083) | 3.84452236 |
| 58 | purine nucleotide salvage (GO:0032261) | 3.83789559 |
| 59 | respiratory electron transport chain (GO:0022904) | 3.81308440 |
| 60 | ventricular cardiac muscle cell development (GO:0055015) | 3.81285155 |
| 61 | oxaloacetate metabolic process (GO:0006107) | 3.79379053 |
| 62 | gluconeogenesis (GO:0006094) | 3.73465278 |
| 63 | carnitine transmembrane transport (GO:1902603) | 3.72304158 |
| 64 | muscle hypertrophy (GO:0014896) | 3.71922061 |
| 65 | electron transport chain (GO:0022900) | 3.70669773 |
| 66 | succinate metabolic process (GO:0006105) | 3.70601350 |
| 67 | skeletal muscle adaptation (GO:0043501) | 3.69696346 |
| 68 | * tricarboxylic acid metabolic process (GO:0072350) | 3.65707662 |
| 69 | regulation of the force of heart contraction (GO:0002026) | 3.64343478 |
| 70 | valine metabolic process (GO:0006573) | 3.63518776 |
| 71 | carnitine transport (GO:0015879) | 3.63411935 |
| 72 | amino-acid betaine transport (GO:0015838) | 3.63411935 |
| 73 | regulation of fatty acid oxidation (GO:0046320) | 3.62843013 |
| 74 | response to muscle activity (GO:0014850) | 3.62101323 |
| 75 | regulation of sulfur metabolic process (GO:0042762) | 3.61263314 |
| 76 | branched-chain amino acid metabolic process (GO:0009081) | 3.59309998 |
| 77 | muscle contraction (GO:0006936) | 3.53342869 |
| 78 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.52068967 |
| 79 | regulation of striated muscle contraction (GO:0006942) | 3.51560918 |
| 80 | fatty acid oxidation (GO:0019395) | 3.50284588 |
| 81 | fatty acid catabolic process (GO:0009062) | 3.49238387 |
| 82 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.46037189 |
| 83 | lipid oxidation (GO:0034440) | 3.42100811 |
| 84 | fructose metabolic process (GO:0006000) | 3.40912116 |
| 85 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.37600507 |
| 86 | regulation of ATP catabolic process (GO:1903289) | 3.36797372 |
| 87 | regulation of ATPase activity (GO:0043462) | 3.36797372 |
| 88 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.36784090 |
| 89 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.36758514 |
| 90 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.36488256 |
| 91 | muscle hypertrophy in response to stress (GO:0003299) | 3.36488256 |
| 92 | cardiac muscle adaptation (GO:0014887) | 3.36488256 |
| 93 | hexose biosynthetic process (GO:0019319) | 3.34580241 |
| 94 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.33156109 |
| 95 | actin filament-based movement (GO:0030048) | 3.30783708 |
| 96 | carnitine metabolic process (GO:0009437) | 3.30650956 |
| 97 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.28151508 |
| 98 | skeletal muscle fiber development (GO:0048741) | 3.27049561 |
| 99 | monosaccharide biosynthetic process (GO:0046364) | 3.25854311 |
| 100 | deoxyribonucleotide catabolic process (GO:0009264) | 3.25324489 |
| 101 | regulation of sequestering of triglyceride (GO:0010889) | 3.23249243 |
| 102 | glycogen biosynthetic process (GO:0005978) | 3.21698434 |
| 103 | glucan biosynthetic process (GO:0009250) | 3.21698434 |
| 104 | ubiquinone biosynthetic process (GO:0006744) | 3.21355784 |
| 105 | quinone biosynthetic process (GO:1901663) | 3.21355784 |
| 106 | regulation of cardioblast differentiation (GO:0051890) | 3.18651030 |
| 107 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.16993374 |
| 108 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.16993374 |
| 109 | galactose catabolic process (GO:0019388) | 3.14534538 |
| 110 | nucleotide salvage (GO:0043173) | 3.12182134 |
| 111 | 4-hydroxyproline metabolic process (GO:0019471) | 3.11665074 |
| 112 | cell communication involved in cardiac conduction (GO:0086065) | 3.10688721 |
| 113 | muscle system process (GO:0003012) | 3.10300888 |
| 114 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.07472651 |
| 115 | deoxyribose phosphate catabolic process (GO:0046386) | 3.01951741 |
| 116 | regulation of membrane repolarization (GO:0060306) | 3.01834392 |
| 117 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.99952737 |
| 118 | Peyers patch development (GO:0048541) | 2.99952737 |
| 119 | quaternary ammonium group transport (GO:0015697) | 2.99587233 |
| 120 | myotube cell development (GO:0014904) | 2.97064233 |
| 121 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.95741105 |
| 122 | striated muscle cell development (GO:0055002) | 2.95218286 |
| 123 | glycogen catabolic process (GO:0005980) | 2.94849811 |
| 124 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.93047179 |
| 125 | ATP biosynthetic process (GO:0006754) | 2.91593948 |
| 126 | negative regulation of necroptotic process (GO:0060546) | 2.91480484 |
| 127 | monocarboxylic acid catabolic process (GO:0072329) | 2.91284867 |
| 128 | trabecula formation (GO:0060343) | 2.90003861 |
| 129 | short-chain fatty acid metabolic process (GO:0046459) | 2.89138984 |
| 130 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.87689305 |
| 131 | regulation of cell communication by electrical coupling (GO:0010649) | 2.87579067 |
| 132 | aerobic respiration (GO:0009060) | 2.87384158 |
| 133 | ubiquinone metabolic process (GO:0006743) | 2.84664679 |
| 134 | cell communication by electrical coupling (GO:0010644) | 2.84263060 |
| 135 | creatine metabolic process (GO:0006600) | 2.83588641 |
| 136 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.80232987 |
| 137 | glycolytic process (GO:0006096) | 2.77886631 |
| 138 | glucan catabolic process (GO:0009251) | 2.75304046 |
| 139 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.74178150 |
| 140 | negative regulation of B cell apoptotic process (GO:0002903) | 2.73884400 |
| 141 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.73787587 |
| 142 | striated muscle atrophy (GO:0014891) | 2.71479485 |
| 143 | positive regulation of myotube differentiation (GO:0010831) | 2.68414155 |
| 144 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.66234497 |
| 145 | striated muscle adaptation (GO:0014888) | 2.63615862 |
| 146 | response to mercury ion (GO:0046689) | 2.61068260 |
| 147 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.59742387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.41271708 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.00398954 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.89050411 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.66754328 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.43206363 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.25981881 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.75010078 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.69938902 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.39595250 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.31028807 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.30955203 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.13459334 |
| 13 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11299878 |
| 14 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.11135551 |
| 15 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.11135551 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06797577 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92570964 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.92341078 |
| 19 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.90758236 |
| 20 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.90728449 |
| 21 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.90024540 |
| 22 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.86066553 |
| 23 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.85714292 |
| 24 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.85540316 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84395030 |
| 26 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.84259821 |
| 27 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.78697521 |
| 28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77381078 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76167982 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71845516 |
| 31 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.71674989 |
| 32 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.67236430 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66562153 |
| 34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.64467680 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.63772317 |
| 36 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61548855 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59859521 |
| 38 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.59629409 |
| 39 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.59550318 |
| 40 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.57638213 |
| 41 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.57135234 |
| 42 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.53515593 |
| 43 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.52880139 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52812525 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50966965 |
| 46 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.50770029 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50326732 |
| 48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.47947172 |
| 49 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.47679698 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47478025 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.47314570 |
| 52 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.46718939 |
| 53 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46701004 |
| 54 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.46670053 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46514003 |
| 56 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.46082214 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44682595 |
| 58 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.44370360 |
| 59 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.44289786 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42186257 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41631966 |
| 62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.40468980 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.40389181 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 1.38933120 |
| 65 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.38769451 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38652342 |
| 67 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38418908 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37217397 |
| 69 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.33551876 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.33244506 |
| 71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.31746125 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30246123 |
| 73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.29805970 |
| 74 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29642090 |
| 75 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29562462 |
| 76 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.28185830 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27674750 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27556137 |
| 79 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.26298843 |
| 80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25951489 |
| 81 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.25890780 |
| 82 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.23408872 |
| 83 | SA1_27219007_Chip-Seq_Bcells_Human | 1.23144103 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22300253 |
| 85 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21528758 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20829280 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.20794317 |
| 88 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20550045 |
| 89 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.20305156 |
| 90 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.19519540 |
| 91 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19342418 |
| 92 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.18498742 |
| 93 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.17192183 |
| 94 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.15533300 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15051526 |
| 96 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.14789626 |
| 97 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.14676666 |
| 98 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14604966 |
| 99 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14457139 |
| 100 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14443779 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14397850 |
| 102 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14088442 |
| 103 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13375634 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13291750 |
| 105 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.11818237 |
| 106 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11369242 |
| 107 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11055773 |
| 108 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.10977778 |
| 109 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.10521116 |
| 110 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.10436864 |
| 111 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10119517 |
| 112 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09915426 |
| 113 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.09760178 |
| 114 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.09484898 |
| 115 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09298648 |
| 116 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.09065762 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08933810 |
| 118 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08892164 |
| 119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08248987 |
| 120 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07789339 |
| 121 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07688759 |
| 122 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.07131745 |
| 123 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06021096 |
| 124 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.05631348 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05330381 |
| 126 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04048229 |
| 127 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.03228985 |
| 128 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02800361 |
| 129 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.02635882 |
| 130 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02610831 |
| 131 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02266320 |
| 132 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02088647 |
| 133 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01163843 |
| 134 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00958984 |
| 135 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00218163 |
| 136 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99449730 |
| 137 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97926947 |
| 138 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.97738233 |
| 139 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95752568 |
| 140 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95010984 |
| 141 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93191759 |
| 142 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92428302 |
| 143 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.92251730 |
| 144 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.92200758 |
| 145 | P68_20966046_ChIP-Seq_HELA_Human | 0.90654598 |
| 146 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.90318203 |
| 147 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.90243402 |
| 148 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88155488 |
| 149 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.86777311 |
| 150 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.86516810 |
| 151 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.86322415 |
| 152 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.85931194 |
| 153 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85919977 |
| 154 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.85441380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 5.49810184 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.42684386 |
| 3 | MP0003646_muscle_fatigue | 4.44869294 |
| 4 | MP0004215_abnormal_myocardial_fiber | 4.11843894 |
| 5 | MP0000751_myopathy | 4.04251599 |
| 6 | MP0005330_cardiomyopathy | 3.75266817 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.69515059 |
| 8 | MP0000749_muscle_degeneration | 3.17717819 |
| 9 | MP0002972_abnormal_cardiac_muscle | 2.80397743 |
| 10 | MP0008775_abnormal_heart_ventricle | 2.72418414 |
| 11 | MP0004087_abnormal_muscle_fiber | 2.71490640 |
| 12 | MP0010630_abnormal_cardiac_muscle | 2.59461132 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.49295328 |
| 14 | MP0005385_cardiovascular_system_phenoty | 2.46904814 |
| 15 | MP0001544_abnormal_cardiovascular_syste | 2.46904814 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.40881478 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 2.28434209 |
| 18 | MP0006138_congestive_heart_failure | 2.22922983 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.22904528 |
| 20 | MP0003221_abnormal_cardiomyocyte_apopto | 2.18891674 |
| 21 | MP0004130_abnormal_muscle_cell | 2.17892955 |
| 22 | MP0003828_pulmonary_edema | 2.17690251 |
| 23 | MP0002269_muscular_atrophy | 2.11064539 |
| 24 | MP0002106_abnormal_muscle_physiology | 2.05597276 |
| 25 | MP0003567_abnormal_fetal_cardiomyocyte | 1.94550760 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.81781757 |
| 27 | MP0004484_altered_response_of | 1.76584090 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.75554848 |
| 29 | MP0005369_muscle_phenotype | 1.62036923 |
| 30 | MP0004233_abnormal_muscle_weight | 1.61422174 |
| 31 | MP0000747_muscle_weakness | 1.60770364 |
| 32 | MP0004085_abnormal_heartbeat | 1.59951384 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.57504797 |
| 34 | MP0002127_abnormal_cardiovascular_syste | 1.55682568 |
| 35 | MP0000759_abnormal_skeletal_muscle | 1.54902988 |
| 36 | MP0005670_abnormal_white_adipose | 1.53757837 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.39929272 |
| 38 | MP0004145_abnormal_muscle_electrophysio | 1.39014960 |
| 39 | MP0009278_abnormal_bone_marrow | 1.30622590 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.26774082 |
| 41 | MP0003279_aneurysm | 1.24739848 |
| 42 | MP0001727_abnormal_embryo_implantation | 1.23385203 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.20703755 |
| 44 | MP0000266_abnormal_heart_morphology | 1.20381905 |
| 45 | MP0002822_catalepsy | 1.18671390 |
| 46 | MP0000343_altered_response_to | 1.16977065 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 1.16744369 |
| 48 | MP0004043_abnormal_pH_regulation | 1.13327686 |
| 49 | MP0005332_abnormal_amino_acid | 1.08342029 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.05155885 |
| 51 | MP0005165_increased_susceptibility_to | 1.04757075 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.03250536 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.03250536 |
| 54 | MP0005085_abnormal_gallbladder_physiolo | 1.02740535 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.01843081 |
| 56 | MP0005266_abnormal_metabolism | 1.00344859 |
| 57 | MP0005365_abnormal_bile_salt | 0.99633407 |
| 58 | MP0002332_abnormal_exercise_endurance | 0.98176214 |
| 59 | MP0005360_urolithiasis | 0.98066562 |
| 60 | MP0002234_abnormal_pharynx_morphology | 0.97759993 |
| 61 | MP0004858_abnormal_nervous_system | 0.97215057 |
| 62 | MP0004272_abnormal_basement_membrane | 0.96989077 |
| 63 | MP0009840_abnormal_foam_cell | 0.95363049 |
| 64 | MP0005375_adipose_tissue_phenotype | 0.94575388 |
| 65 | MP0001661_extended_life_span | 0.93822312 |
| 66 | MP0009643_abnormal_urine_homeostasis | 0.92166737 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 0.86007246 |
| 68 | MP0003186_abnormal_redox_activity | 0.85087641 |
| 69 | MP0002128_abnormal_blood_circulation | 0.85002143 |
| 70 | MP0006054_spinal_hemorrhage | 0.84008079 |
| 71 | MP0003950_abnormal_plasma_membrane | 0.83849597 |
| 72 | MP0005083_abnormal_biliary_tract | 0.82820436 |
| 73 | MP0002139_abnormal_hepatobiliary_system | 0.82528750 |
| 74 | MP0004185_abnormal_adipocyte_glucose | 0.82079435 |
| 75 | MP0008260_abnormal_autophagy | 0.80457025 |
| 76 | MP0005451_abnormal_body_composition | 0.80144069 |
| 77 | MP0003984_embryonic_growth_retardation | 0.79689650 |
| 78 | MP0002088_abnormal_embryonic_growth/wei | 0.78468930 |
| 79 | MP0004510_myositis | 0.78340136 |
| 80 | MP0000230_abnormal_systemic_arterial | 0.77999217 |
| 81 | MP0002166_altered_tumor_susceptibility | 0.77433658 |
| 82 | MP0002653_abnormal_ependyma_morphology | 0.74885176 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 0.74635640 |
| 84 | MP0001879_abnormal_lymphatic_vessel | 0.74203557 |
| 85 | MP0003195_calcinosis | 0.73909697 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 0.73679019 |
| 87 | MP0005025_abnormal_response_to | 0.73550352 |
| 88 | MP0003252_abnormal_bile_duct | 0.70926627 |
| 89 | MP0003763_abnormal_thymus_physiology | 0.66628487 |
| 90 | MP0005464_abnormal_platelet_physiology | 0.66004492 |
| 91 | MP0002396_abnormal_hematopoietic_system | 0.65546946 |
| 92 | MP0009697_abnormal_copulation | 0.64885384 |
| 93 | MP0005166_decreased_susceptibility_to | 0.63842506 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.62433512 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 0.62336548 |
| 96 | MP0001672_abnormal_embryogenesis/_devel | 0.60964500 |
| 97 | MP0005380_embryogenesis_phenotype | 0.60964500 |
| 98 | MP0002971_abnormal_brown_adipose | 0.60395482 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58764365 |
| 100 | MP0000767_abnormal_smooth_muscle | 0.57915739 |
| 101 | MP0004147_increased_porphyrin_level | 0.57626084 |
| 102 | MP0001853_heart_inflammation | 0.57543905 |
| 103 | MP0000733_abnormal_muscle_development | 0.55075845 |
| 104 | MP0003123_paternal_imprinting | 0.54781635 |
| 105 | MP0009384_cardiac_valve_regurgitation | 0.54781306 |
| 106 | MP0005334_abnormal_fat_pad | 0.54542101 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.54137169 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 0.53657768 |
| 109 | MP0002108_abnormal_muscle_morphology | 0.53096847 |
| 110 | MP0001756_abnormal_urination | 0.52950286 |
| 111 | MP0005535_abnormal_body_temperature | 0.52807582 |
| 112 | MP0001666_abnormal_nutrient_absorption | 0.52604229 |
| 113 | MP0003075_altered_response_to | 0.51714879 |
| 114 | MP0003878_abnormal_ear_physiology | 0.51310726 |
| 115 | MP0005377_hearing/vestibular/ear_phenot | 0.51310726 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 0.51273356 |
| 117 | MP0000681_abnormal_thyroid_gland | 0.51181195 |
| 118 | MP0002925_abnormal_cardiovascular_devel | 0.51052348 |
| 119 | MP0000358_abnormal_cell_content/ | 0.50969657 |
| 120 | MP0000685_abnormal_immune_system | 0.50547568 |
| 121 | MP0001730_embryonic_growth_arrest | 0.49962530 |
| 122 | MP0000609_abnormal_liver_physiology | 0.49703542 |
| 123 | MP0003948_abnormal_gas_homeostasis | 0.48717572 |
| 124 | MP0008874_decreased_physiological_sensi | 0.47838686 |
| 125 | MP0000003_abnormal_adipose_tissue | 0.47726356 |
| 126 | MP0001614_abnormal_blood_vessel | 0.47661381 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.46822698 |
| 128 | MP0001697_abnormal_embryo_size | 0.46491803 |
| 129 | MP0003879_abnormal_hair_cell | 0.46440804 |
| 130 | MP0002970_abnormal_white_adipose | 0.46240047 |
| 131 | MP0000372_irregular_coat_pigmentation | 0.46122979 |
| 132 | MP0009764_decreased_sensitivity_to | 0.45501710 |
| 133 | MP0001764_abnormal_homeostasis | 0.45461423 |
| 134 | MP0009115_abnormal_fat_cell | 0.44398964 |
| 135 | MP0003866_abnormal_defecation | 0.44092878 |
| 136 | MP0001873_stomach_inflammation | 0.43842068 |
| 137 | MP0008469_abnormal_protein_level | 0.42318713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.00620230 |
| 2 | Nemaline bodies (HP:0003798) | 7.90532022 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.74941136 |
| 4 | Sudden death (HP:0001699) | 6.61759081 |
| 5 | Ventricular tachycardia (HP:0004756) | 6.02298190 |
| 6 | Myopathic facies (HP:0002058) | 5.34771273 |
| 7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 5.23975402 |
| 8 | Myoglobinuria (HP:0002913) | 5.10337627 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 5.02618881 |
| 10 | Lipoatrophy (HP:0100578) | 4.89581086 |
| 11 | Atrial fibrillation (HP:0005110) | 4.85498385 |
| 12 | Subaortic stenosis (HP:0001682) | 4.79091633 |
| 13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.79091633 |
| 14 | Calf muscle hypertrophy (HP:0008981) | 4.60514530 |
| 15 | Primary atrial arrhythmia (HP:0001692) | 4.51272198 |
| 16 | Supraventricular tachycardia (HP:0004755) | 4.47098112 |
| 17 | Palpitations (HP:0001962) | 4.42115202 |
| 18 | Supraventricular arrhythmia (HP:0005115) | 4.40776743 |
| 19 | Exercise-induced myalgia (HP:0003738) | 4.37917168 |
| 20 | Hypoglycemic coma (HP:0001325) | 4.30003241 |
| 21 | Distal arthrogryposis (HP:0005684) | 4.15742345 |
| 22 | Dilated cardiomyopathy (HP:0001644) | 4.14961966 |
| 23 | Right ventricular cardiomyopathy (HP:0011663) | 4.11838344 |
| 24 | Rhabdomyolysis (HP:0003201) | 4.11730004 |
| 25 | Muscle fiber splitting (HP:0003555) | 4.10614010 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 4.05543832 |
| 27 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.04081781 |
| 28 | Hepatic necrosis (HP:0002605) | 3.97175866 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.94647771 |
| 30 | Ketoacidosis (HP:0001993) | 3.93074402 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.89208360 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.75205443 |
| 33 | Ulnar deviation of the wrist (HP:0003049) | 3.72712479 |
| 34 | Rimmed vacuoles (HP:0003805) | 3.69141267 |
| 35 | Syncope (HP:0001279) | 3.67325705 |
| 36 | Round ear (HP:0100830) | 3.53622970 |
| 37 | Ventricular arrhythmia (HP:0004308) | 3.50966656 |
| 38 | Generalized aminoaciduria (HP:0002909) | 3.45837981 |
| 39 | Ragged-red muscle fibers (HP:0003200) | 3.38684210 |
| 40 | Prolonged QT interval (HP:0001657) | 3.26560370 |
| 41 | * Dicarboxylic aciduria (HP:0003215) | 3.26362712 |
| 42 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.26362712 |
| 43 | Hyporeflexia of lower limbs (HP:0002600) | 3.25196545 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 3.23145632 |
| 45 | Ketosis (HP:0001946) | 3.21398407 |
| 46 | Bundle branch block (HP:0011710) | 3.18384906 |
| 47 | Hepatocellular necrosis (HP:0001404) | 3.15432283 |
| 48 | Increased connective tissue (HP:0009025) | 3.14610779 |
| 49 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.12434600 |
| 50 | EMG: neuropathic changes (HP:0003445) | 3.12416299 |
| 51 | EMG: myopathic abnormalities (HP:0003458) | 3.09999788 |
| 52 | Atrioventricular block (HP:0001678) | 3.06898602 |
| 53 | Calcaneovalgus deformity (HP:0001848) | 3.01492101 |
| 54 | Hyperglycinuria (HP:0003108) | 2.92757721 |
| 55 | Heart block (HP:0012722) | 2.91825938 |
| 56 | Increased muscle lipid content (HP:0009058) | 2.89844733 |
| 57 | Acute necrotizing encephalopathy (HP:0006965) | 2.89238828 |
| 58 | Bulbar palsy (HP:0001283) | 2.86749459 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 2.86345521 |
| 60 | Acute encephalopathy (HP:0006846) | 2.84186990 |
| 61 | Ventricular fibrillation (HP:0001663) | 2.81327554 |
| 62 | Areflexia of lower limbs (HP:0002522) | 2.79817527 |
| 63 | Cerebral edema (HP:0002181) | 2.79204591 |
| 64 | Conjunctival hamartoma (HP:0100780) | 2.75911434 |
| 65 | Hyperammonemia (HP:0001987) | 2.74511568 |
| 66 | Abnormal atrioventricular conduction (HP:0005150) | 2.73770137 |
| 67 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.68174567 |
| 68 | Deformed tarsal bones (HP:0008119) | 2.63177966 |
| 69 | Increased CSF lactate (HP:0002490) | 2.59293371 |
| 70 | Lactic acidosis (HP:0003128) | 2.58983723 |
| 71 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.58481798 |
| 72 | Mitochondrial inheritance (HP:0001427) | 2.53386125 |
| 73 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.46751759 |
| 74 | Abnormality of alanine metabolism (HP:0010916) | 2.46751759 |
| 75 | Hyperalaninemia (HP:0003348) | 2.46751759 |
| 76 | Abnormality of glycine metabolism (HP:0010895) | 2.46532697 |
| 77 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.46532697 |
| 78 | Increased intramyocellular lipid droplets (HP:0012240) | 2.44237610 |
| 79 | Myotonia (HP:0002486) | 2.44022272 |
| 80 | Proximal tubulopathy (HP:0000114) | 2.42048309 |
| 81 | Type 1 muscle fiber predominance (HP:0003803) | 2.40861726 |
| 82 | Nausea (HP:0002018) | 2.38042883 |
| 83 | Progressive muscle weakness (HP:0003323) | 2.37735139 |
| 84 | Esophageal neoplasm (HP:0100751) | 2.37117750 |
| 85 | Neoplasm of head and neck (HP:0012288) | 2.37117750 |
| 86 | Exercise intolerance (HP:0003546) | 2.35414206 |
| 87 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.34516874 |
| 88 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.34516874 |
| 89 | Malignant hyperthermia (HP:0002047) | 2.32034793 |
| 90 | Palmoplantar keratoderma (HP:0000982) | 2.30256455 |
| 91 | Abnormal EKG (HP:0003115) | 2.27469255 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27173947 |
| 93 | Scapular winging (HP:0003691) | 2.27084606 |
| 94 | * Cerebral palsy (HP:0100021) | 2.25215055 |
| 95 | Progressive macrocephaly (HP:0004481) | 2.24568374 |
| 96 | Late onset (HP:0003584) | 2.22190405 |
| 97 | Left ventricular hypertrophy (HP:0001712) | 2.21944412 |
| 98 | Difficulty running (HP:0009046) | 2.21744089 |
| 99 | Absent phalangeal crease (HP:0006109) | 2.21009822 |
| 100 | Reticulocytosis (HP:0001923) | 2.20095769 |
| 101 | Respiratory failure (HP:0002878) | 2.19610032 |
| 102 | Increased serum pyruvate (HP:0003542) | 2.18542850 |
| 103 | Abnormality of glycolysis (HP:0004366) | 2.18542850 |
| 104 | Difficulty climbing stairs (HP:0003551) | 2.15317110 |
| 105 | Limb-girdle muscle atrophy (HP:0003797) | 2.14874865 |
| 106 | Abnormality of the foot musculature (HP:0001436) | 2.12457290 |
| 107 | Agammaglobulinemia (HP:0004432) | 2.08679509 |
| 108 | Neonatal death (HP:0003811) | 2.07429272 |
| 109 | Generalized muscle weakness (HP:0003324) | 2.07006401 |
| 110 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.06786051 |
| 111 | Metabolic acidosis (HP:0001942) | 2.06769187 |
| 112 | Muscle stiffness (HP:0003552) | 2.05270739 |
| 113 | Cholelithiasis (HP:0001081) | 2.04867679 |
| 114 | Gout (HP:0001997) | 2.03757866 |
| 115 | Increased serum lactate (HP:0002151) | 2.00987640 |
| 116 | Lethargy (HP:0001254) | 2.00806163 |
| 117 | Foot dorsiflexor weakness (HP:0009027) | 1.99639503 |
| 118 | Frequent falls (HP:0002359) | 1.99600457 |
| 119 | Abnormal gallbladder physiology (HP:0012438) | 1.98886830 |
| 120 | Cholecystitis (HP:0001082) | 1.98886830 |
| 121 | Weak cry (HP:0001612) | 1.97697160 |
| 122 | Distal lower limb muscle weakness (HP:0009053) | 1.97520396 |
| 123 | Neck muscle weakness (HP:0000467) | 1.92009425 |
| 124 | Oligomenorrhea (HP:0000876) | 1.90309325 |
| 125 | Lipid accumulation in hepatocytes (HP:0006561) | 1.89923600 |
| 126 | Abnormality of the calcaneus (HP:0008364) | 1.87668561 |
| 127 | Gowers sign (HP:0003391) | 1.86179374 |
| 128 | Sudden cardiac death (HP:0001645) | 1.85369749 |
| 129 | Large for gestational age (HP:0001520) | 1.84763103 |
| 130 | Congestive heart failure (HP:0001635) | 1.84372875 |
| 131 | Hamartoma of the eye (HP:0010568) | 1.84009901 |
| 132 | Pheochromocytoma (HP:0002666) | 1.83859358 |
| 133 | Paralysis (HP:0003470) | 1.82267009 |
| 134 | Waddling gait (HP:0002515) | 1.82207070 |
| 135 | Glycosuria (HP:0003076) | 1.79884456 |
| 136 | Abnormality of urine glucose concentration (HP:0011016) | 1.79884456 |
| 137 | Lower limb amyotrophy (HP:0007210) | 1.79538107 |
| 138 | Diaphragmatic weakness (HP:0009113) | 1.69319490 |
| 139 | Systemic lupus erythematosus (HP:0002725) | 1.66724373 |
| 140 | Abnormal gallbladder morphology (HP:0012437) | 1.66385858 |
| 141 | Abnormality of the tricuspid valve (HP:0001702) | 1.65673859 |
| 142 | Muscle fiber atrophy (HP:0100295) | 1.65468934 |
| 143 | Abnormal finger flexion creases (HP:0006143) | 1.61737138 |
| 144 | Microvesicular hepatic steatosis (HP:0001414) | 1.61275188 |
| 145 | Fetal akinesia sequence (HP:0001989) | 1.57867061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PKN2 | 4.54096469 |
| 2 | TTN | 4.42842547 |
| 3 | BCKDK | 4.12923515 |
| 4 | TRIB3 | 3.83226592 |
| 5 | TESK2 | 3.49595195 |
| 6 | OBSCN | 3.41715615 |
| 7 | MYLK | 3.27462094 |
| 8 | LMTK2 | 3.23580859 |
| 9 | NEK1 | 3.06351525 |
| 10 | PDK3 | 2.99662714 |
| 11 | PDK4 | 2.99662714 |
| 12 | FLT3 | 2.96123311 |
| 13 | TESK1 | 2.73151572 |
| 14 | PHKG1 | 2.37972641 |
| 15 | PHKG2 | 2.37972641 |
| 16 | TIE1 | 2.25685467 |
| 17 | VRK2 | 2.00181073 |
| 18 | DMPK | 1.76429199 |
| 19 | STK24 | 1.71276461 |
| 20 | LIMK1 | 1.64096699 |
| 21 | NME2 | 1.61023714 |
| 22 | ILK | 1.57179812 |
| 23 | MAPKAPK3 | 1.53086336 |
| 24 | PDK2 | 1.51481747 |
| 25 | MAP2K3 | 1.49327286 |
| 26 | PIM2 | 1.40000953 |
| 27 | KDR | 1.37555586 |
| 28 | WNK4 | 1.31759805 |
| 29 | SMG1 | 1.31515658 |
| 30 | PIK3CA | 1.29897275 |
| 31 | PINK1 | 1.18379214 |
| 32 | MUSK | 1.16648973 |
| 33 | EEF2K | 1.15027949 |
| 34 | ERN1 | 1.15001088 |
| 35 | TGFBR1 | 1.14172273 |
| 36 | WEE1 | 1.12287302 |
| 37 | PRPF4B | 1.11301789 |
| 38 | MAP3K10 | 1.07976085 |
| 39 | LRRK2 | 1.07014022 |
| 40 | MAP4K1 | 1.05805703 |
| 41 | STK4 | 1.01192566 |
| 42 | TGFBR2 | 0.98556705 |
| 43 | TNK2 | 0.98449214 |
| 44 | RIPK1 | 0.92047201 |
| 45 | NME1 | 0.91475256 |
| 46 | MAP3K3 | 0.90085403 |
| 47 | INSRR | 0.89079374 |
| 48 | ZAK | 0.87953674 |
| 49 | ARAF | 0.87609124 |
| 50 | ICK | 0.87500926 |
| 51 | STK38L | 0.85441522 |
| 52 | RPS6KB2 | 0.84306114 |
| 53 | CAMK2G | 0.83991289 |
| 54 | SIK1 | 0.83682226 |
| 55 | PDGFRA | 0.82763775 |
| 56 | PRKD1 | 0.82626733 |
| 57 | PTK6 | 0.80972757 |
| 58 | PASK | 0.76365424 |
| 59 | CCNB1 | 0.73934906 |
| 60 | MAP3K7 | 0.73356551 |
| 61 | MAPK4 | 0.72109589 |
| 62 | SCYL2 | 0.69934102 |
| 63 | PAK4 | 0.69453317 |
| 64 | NEK9 | 0.69368313 |
| 65 | TAOK1 | 0.67301820 |
| 66 | MAP3K13 | 0.65268951 |
| 67 | MAP3K5 | 0.63466775 |
| 68 | PRKAA2 | 0.62594269 |
| 69 | TRPM7 | 0.62374234 |
| 70 | CDC42BPA | 0.61433590 |
| 71 | PRKAA1 | 0.61184419 |
| 72 | CDK4 | 0.60959858 |
| 73 | MAPK12 | 0.60664315 |
| 74 | AKT2 | 0.59937762 |
| 75 | DAPK3 | 0.59726036 |
| 76 | PAK3 | 0.58872222 |
| 77 | ROCK1 | 0.57897677 |
| 78 | MAP2K4 | 0.56602818 |
| 79 | MAPK11 | 0.56425229 |
| 80 | CAMK4 | 0.54507557 |
| 81 | DAPK1 | 0.54451721 |
| 82 | MAP2K2 | 0.53489656 |
| 83 | KIT | 0.52707161 |
| 84 | AURKA | 0.51982348 |
| 85 | MAP3K1 | 0.50821180 |
| 86 | RPS6KA2 | 0.49153575 |
| 87 | CAMK2D | 0.48678247 |
| 88 | BRSK2 | 0.48599858 |
| 89 | EPHA3 | 0.48485887 |
| 90 | AURKB | 0.48077301 |
| 91 | RPS6KL1 | 0.47937513 |
| 92 | RPS6KC1 | 0.47937513 |
| 93 | ABL2 | 0.47760063 |
| 94 | STK16 | 0.46746906 |
| 95 | TYK2 | 0.46653750 |
| 96 | MAP3K11 | 0.46423257 |
| 97 | MAP3K8 | 0.45070657 |
| 98 | SYK | 0.44156755 |
| 99 | RPS6KA6 | 0.42269004 |
| 100 | GRK7 | 0.41877695 |
| 101 | BUB1 | 0.40935638 |
| 102 | FGFR4 | 0.39232985 |
| 103 | CAMK2B | 0.38901502 |
| 104 | GRK6 | 0.38620535 |
| 105 | PRKG2 | 0.36557467 |
| 106 | DYRK3 | 0.36302154 |
| 107 | RPS6KA4 | 0.35124819 |
| 108 | IKBKE | 0.34856763 |
| 109 | EIF2AK3 | 0.34740640 |
| 110 | ACVR1B | 0.34610993 |
| 111 | PAK2 | 0.32942011 |
| 112 | BTK | 0.32338508 |
| 113 | NEK2 | 0.32336765 |
| 114 | RPS6KA1 | 0.32295498 |
| 115 | PIK3CG | 0.31631977 |
| 116 | MTOR | 0.31291412 |
| 117 | TAOK2 | 0.31204430 |
| 118 | EPHA2 | 0.30723194 |
| 119 | MARK2 | 0.30187637 |
| 120 | CAMK1 | 0.29570394 |
| 121 | RPS6KA5 | 0.29545138 |
| 122 | BLK | 0.29432636 |
| 123 | VRK1 | 0.29143911 |
| 124 | TTK | 0.28481896 |
| 125 | CDK8 | 0.28432467 |
| 126 | WNK3 | 0.28351071 |
| 127 | PRKACB | 0.27860911 |
| 128 | MAP2K1 | 0.27726602 |
| 129 | MAPK7 | 0.26631135 |
| 130 | PDPK1 | 0.26051181 |
| 131 | CDK7 | 0.25448053 |
| 132 | MAPK3 | 0.25321173 |
| 133 | MATK | 0.25203458 |
| 134 | RET | 0.24277230 |
| 135 | RAF1 | 0.24113955 |
| 136 | ZAP70 | 0.23972986 |
| 137 | TBK1 | 0.22388673 |
| 138 | DYRK1B | 0.22192833 |
| 139 | PRKACG | 0.21928826 |
| 140 | CSF1R | 0.20389690 |
| 141 | MAP2K6 | 0.20342352 |
| 142 | STK10 | 0.20152452 |
| 143 | CDC7 | 0.19947467 |
| 144 | TEC | 0.19410927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.74708293 |
| 2 | * 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.04705670 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.56864508 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.49517084 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.10611077 |
| 6 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.85713999 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.70414804 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.63821067 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.52924750 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.47849447 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45207676 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.26736026 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.13294319 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.11658918 |
| 15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.08770194 |
| 16 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.78955028 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78028602 |
| 18 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.72464442 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.69130932 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.53865804 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.52904979 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51492359 |
| 23 | DNA replication_Homo sapiens_hsa03030 | 1.47337980 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.44650287 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37019216 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31097404 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26284605 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24805621 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24413232 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.24262892 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.19700951 |
| 32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.18980406 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 1.08437396 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02323622 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01886258 |
| 36 | * Peroxisome_Homo sapiens_hsa04146 | 1.01217919 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00579199 |
| 38 | Ribosome_Homo sapiens_hsa03010 | 1.00360498 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99413561 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.98871678 |
| 41 | Mismatch repair_Homo sapiens_hsa03430 | 0.98507443 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93616140 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.93441264 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91314989 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88302921 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.85968654 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 0.85097578 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74945357 |
| 49 | Base excision repair_Homo sapiens_hsa03410 | 0.74082793 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73914927 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73217961 |
| 52 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.71260582 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70935526 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69095113 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68139677 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67210751 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66235219 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66171661 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64750046 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62952822 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61963313 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58678902 |
| 63 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58217743 |
| 64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56589535 |
| 65 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.56221353 |
| 66 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53344902 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52510362 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50554819 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50491216 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.50463223 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50133644 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.49892979 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48982757 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46560323 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46114850 |
| 76 | Proteasome_Homo sapiens_hsa03050 | 0.46002014 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44091198 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40221312 |
| 79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39903425 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38797659 |
| 81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37012321 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36507081 |
| 83 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34976233 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.34681654 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34579702 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32820095 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32236722 |
| 88 | Homologous recombination_Homo sapiens_hsa03440 | 0.31557328 |
| 89 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.31011474 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.30611142 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29480434 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.28897371 |
| 93 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.27457519 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.27291113 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26763068 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26671286 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.24852724 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24538227 |
| 99 | Spliceosome_Homo sapiens_hsa03040 | 0.23297428 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.21700554 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.21311306 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.20835388 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.20344470 |
| 104 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.19581025 |
| 105 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.19485620 |
| 106 | RNA transport_Homo sapiens_hsa03013 | 0.19068014 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.17894759 |
| 108 | RNA degradation_Homo sapiens_hsa03018 | 0.17801995 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.17525805 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16336803 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.15323348 |
| 112 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.14577531 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.14517872 |
| 114 | Cell cycle_Homo sapiens_hsa04110 | 0.14493194 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.14378409 |
| 116 | Pertussis_Homo sapiens_hsa05133 | 0.14097022 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.13914930 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.13569087 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13503478 |
| 120 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.13318890 |
| 121 | Other glycan degradation_Homo sapiens_hsa00511 | 0.12799318 |
| 122 | Allograft rejection_Homo sapiens_hsa05330 | 0.12219995 |
| 123 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.12214341 |
| 124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.11973371 |
| 125 | Platelet activation_Homo sapiens_hsa04611 | 0.10878376 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.10717655 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.10334279 |

